Fda grants 510(k) market clearance to vivos therapeutics' mmrna oral appliance for treating mild to moderate sleep apnea

Part of the vivos system treatment, the mmrna device represents a highly effective non-surgical, non-invasive and non-pharmaceutical alternative for patients suffering from osa

VVOS Ratings Summary

VVOS Quant Ranking